Update on the Phase 4 Confirmatory Study of ADUHELM®
Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 249.61 -4.23 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.84 | 52 Week High | $333.65 | |||
| Open | $251.66 | 52 Week Low | $223.02 | |||
| Day High | $252.27 | P/E | 31.96 | |||
| Day Low | $249.61 | EPS | $7.81 | |||
| Volume | 26,438 | |||||



